"Leishmania donovani" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors.
| Descriptor ID |
D007893
|
| MeSH Number(s) |
B01.268.475.868.488.230
|
| Concept/Terms |
Leishmania donovani- Leishmania donovani
- Leishmania donovanus
- donovanus, Leishmania
- Leishmania (Leishmania) donovani
- Leishmania leishmania donovani
- Leishmania leishmania donovanus
- donovani, Leishmania leishmania
- donovanus, Leishmania leishmania
- leishmania donovanus, Leishmania
|
Below are MeSH descriptors whose meaning is more general than "Leishmania donovani".
Below are MeSH descriptors whose meaning is more specific than "Leishmania donovani".
This graph shows the total number of publications written about "Leishmania donovani" by people in this website by year, and whether "Leishmania donovani" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmania donovani" by people in Profiles.
-
Guha R, Das S, Ghosh J, Naskar K, Mandala A, Sundar S, Dujardin JC, Roy S. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani. Vaccine. 2013 Apr 08; 31(15):1905-15.
-
Stec J, Huang Q, Pieroni M, Kaiser M, Fomovska A, Mui E, Witola WH, Bettis S, McLeod R, Brun R, Kozikowski AP. Synthesis, biological evaluation, and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania. J Med Chem. 2012 Apr 12; 55(7):3088-100.
-
Kumar B, Ghimire A, Karki S, Upadhyaya P. Primary laryngeal leishmaniasis: a rare case report. Indian J Pathol Microbiol. 2009 Jan-Mar; 52(1):62-4.
-
Squires KE, Rosenkaimer F, Sherwood JA, Forni AL, Were JB, Murray HW. Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. Am J Trop Med Hyg. 1993 May; 48(5):666-9.